These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28705298)

  • 21. Improving Rehabilitative Care of Methamphetamine Users in Germany: The Expert's Perspective.
    Hoffmann L; Buchenauer L; Schumann N; Schröder SL; Martin O; Richter M
    Qual Health Res; 2019 Jan; 29(2):248-259. PubMed ID: 30129874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Metamphetamine-related disorders: Diagnostics and therapy].
    Milin S; Schäfer I
    Fortschr Neurol Psychiatr; 2019 Jun; 87(6):385-398. PubMed ID: 31261418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methamphetamine abuse.
    Winslow BT; Voorhees KI; Pehl KA
    Am Fam Physician; 2007 Oct; 76(8):1169-74. PubMed ID: 17990840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder: A Review.
    Paulus MP; Stewart JL
    JAMA Psychiatry; 2020 Sep; 77(9):959-966. PubMed ID: 32267484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of the clinical pharmacology of methamphetamine.
    Cruickshank CC; Dyer KR
    Addiction; 2009 Jul; 104(7):1085-99. PubMed ID: 19426289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Stimulant dependence].
    Kishimoto H
    Ryoikibetsu Shokogun Shirizu; 2003; (40):505-6. PubMed ID: 14626171
    [No Abstract]   [Full Text] [Related]  

  • 27. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
    Stip E; Tourjman V
    Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment.
    Robertson CL; Ishibashi K; Chudzynski J; Mooney LJ; Rawson RA; Dolezal BA; Cooper CB; Brown AK; Mandelkern MA; London ED
    Neuropsychopharmacology; 2016 May; 41(6):1629-36. PubMed ID: 26503310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extending contingency management to the treatment of methamphetamine use disorders.
    Higgins ST
    Am J Psychiatry; 2006 Nov; 163(11):1870-2. PubMed ID: 17074933
    [No Abstract]   [Full Text] [Related]  

  • 30. 'Tweaking 12-Step': the potential role of 12-Step self-help group involvement in methamphetamine recovery.
    Donovan DM; Wells EA
    Addiction; 2007 Apr; 102 Suppl 1():121-9. PubMed ID: 17493061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
    Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Methamphetamine dependence: Consequences and complications].
    Karila L; Petit A; Cottencin O; Reynaud M
    Presse Med; 2010 Dec; 39(12):1246-53. PubMed ID: 20971608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.
    Dold M; Samara MT; Li C; Tardy M; Leucht S
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009831. PubMed ID: 25592299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. When treatment meets research: clinical perspectives from the CSAT Methamphetamine Treatment Project.
    Obert JL; Brown AH; Zweben J; Christian D; Delmhorst J; Minsky S; Morrisey P; Vandersloot D; Weiner A
    J Subst Abuse Treat; 2005 Apr; 28(3):231-7. PubMed ID: 15857723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependence.
    Ezard N; Dunlop A; Clifford B; Bruno R; Carr A; Bissaker A; Lintzeris N
    BMC Psychiatry; 2016 Dec; 16(1):428. PubMed ID: 27905916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapeutic agents in the treatment of methamphetamine dependence.
    Morley KC; Cornish JL; Faingold A; Wood K; Haber PS
    Expert Opin Investig Drugs; 2017 May; 26(5):563-578. PubMed ID: 28351169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bupropion for the treatment of methamphetamine dependence.
    Elkashef AM; Rawson RA; Anderson AL; Li SH; Holmes T; Smith EV; Chiang N; Kahn R; Vocci F; Ling W; Pearce VJ; McCann M; Campbell J; Gorodetzky C; Haning W; Carlton B; Mawhinney J; Weis D
    Neuropsychopharmacology; 2008 Apr; 33(5):1162-70. PubMed ID: 17581531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity.
    Elkashef A; Rawson RA; Smith E; Pearce V; Flammino F; Campbell J; Donovick R; Gorodetzky C; Haning W; Mawhinney J; McCann M; Weis D; Williams L; Ling W; Vocci F
    Addiction; 2007 Apr; 102 Suppl 1():107-13. PubMed ID: 17493059
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.